166 filings
6-K
GLMD
Galmed Pharmaceuticals Ltd
5 Jun 24
Current report (foreign)
4:16pm
6-K
GLMD
Galmed Pharmaceuticals Ltd
30 May 24
Current report (foreign)
4:30pm
6-K
GLMD
Galmed Pharmaceuticals Ltd
19 Mar 24
Current report (foreign)
4:30pm
6-K
GLMD
Galmed Pharmaceuticals Ltd
15 Mar 24
Current report (foreign)
9:13am
6-K
GLMD
Galmed Pharmaceuticals Ltd
22 Nov 23
Current report (foreign)
4:05pm
6-K
sku8y62t3iaexnh
20 Nov 23
Galmed Announces a delay in the initiation of its Primary Sclerosing Cholangitis (PSC) Phase 2a Study
4:37pm
6-K
e8vw61f6 yc
26 Sep 23
Galmed Announces Allowance of New Patent for Aramchol for the Treatment of Pulmonary and Dermal Fibrosis
8:51am
6-K
qcvbj1zew62g7ry4
22 Sep 23
Galmed Pharmaceuticals Announces Receipt of Nasdaq Minimum Bid Price Notification
4:15pm
6-K/A
zirfoy9
21 Sep 23
Current report (foreign) (amended)
7:30am
6-K
trnri2j
20 Sep 23
Current report (foreign)
4:30pm
6-K
3787me
13 Sep 23
Current report (foreign)
4:01pm
6-K
5og92
9 Aug 23
Current report (foreign)
4:43pm
6-K
xw3lud
9 Aug 23
Current report (foreign)
4:30pm
6-K
ousom5bjkx
2 Aug 23
Consolidated Financial Statements
4:30pm
6-K
dsgc98xq o5dlhyasmd9
18 Jul 23
Current report (foreign)
9:25am
6-K
8kt77o
14 Jul 23
Galmed Pharmaceuticals Announces Pricing of $7 Million Public Offering
9:44am
6-K
cg4od5if65etwrj5ry1
10 Jul 23
Current report (foreign)
8:10am
6-K
70fzgaw q8g
1 Jun 23
Galmed Pharmaceuticals Reports First Quarter 2023 Financial Results
8:14am
6-K
3m4l44y lb
12 May 23
Current report (foreign)
7:00am
6-K
acvajiq7pui
11 May 23
Current report (foreign)
4:15pm